These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19271101)

  • 1. Effect of lipid-lowering therapy on the progression of intracranial arterial stenosis.
    Tan TY; Kuo YL; Lin WC; Chen TY
    J Neurol; 2009 Feb; 256(2):187-93. PubMed ID: 19271101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up.
    Zhou P; Lu Z; Gao P; Wang P; Cao Z; Zhang G; Wang S; Feng Y; Wang P
    Clin Neurol Neurosurg; 2014 May; 120():6-13. PubMed ID: 24731567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.
    Kwon SU; Cho YJ; Koo JS; Bae HJ; Lee YS; Hong KS; Lee JH; Kim JS
    Stroke; 2005 Apr; 36(4):782-6. PubMed ID: 15746463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible short-term amelioration of basilar plaque by high-dose atorvastatin: use of reductase inhibitors for intracranial plaque stabilization.
    Callahan AS; Berger BL; Beuter MJ; Devlin TG
    J Neuroimaging; 2001 Apr; 11(2):202-4. PubMed ID: 11296593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
    Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
    Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of symptomatic intracranial stenosis.
    Taylor RA; Weigele JB; Kasner SE
    Curr Atheroscler Rep; 2011 Aug; 13(4):321-9. PubMed ID: 21597931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.
    Szapary L; Horvath B; Marton Z; Alexy T; Kesmarky G; Habon T; Szots M; Koltai K; Juricskay I; Czopf J; Toth K
    CNS Drugs; 2004; 18(3):165-72. PubMed ID: 14871160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study.
    Patti G; Tomai F; Melfi R; Ricottini E; Macrì M; Sedati P; Giardina A; Aurigemma C; Leporace M; D'Ambrosio A; Di Sciascio G
    J Am Coll Cardiol; 2013 Apr; 61(13):1379-87. PubMed ID: 23490041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The statin dosage for achieving goal of cholesterol-lowering based on risk stratification in patients with ischemic cerebrovascular diseases].
    Tan ZF; Guo YD; Xu AD; Yang WY; Fu YG; Wang TG
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):280-3. PubMed ID: 19576114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
    Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
    N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning).
    Alexopoulos N; Melek BH; Arepalli CD; Hartlage GR; Chen Z; Kim S; Stillman AE; Raggi P
    J Am Coll Cardiol; 2013 May; 61(19):1956-61. PubMed ID: 23500254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin.
    Lampl Y; Lorberboym M; Gilad R; Vysberg I; Tikozky A; Sadeh M; Boaz M
    Clin Neuropharmacol; 2010 May; 33(3):129-34. PubMed ID: 20502132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
    Schmermund A; Achenbach S; Budde T; Buziashvili Y; Förster A; Friedrich G; Henein M; Kerkhoff G; Knollmann F; Kukharchuk V; Lahiri A; Leischik R; Moshage W; Schartl M; Siffert W; Steinhagen-Thiessen E; Sinitsyn V; Vogt A; Wiedeking B; Erbel R
    Circulation; 2006 Jan; 113(3):427-37. PubMed ID: 16415377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention after ischemic stroke].
    Baumgartner RW; Georgiadis D
    Praxis (Bern 1994); 2003 Jan; 92(5):168-78. PubMed ID: 12643070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of intracranial atherosclerotic disease under modern medical therapy.
    Leung TW; Wang L; Soo YO; Ip VH; Chan AY; Au LW; Fan FS; Lau AY; Leung H; Abrigo J; Wong A; Mok VC; Ng PW; Tsoi TH; Li SH; Man CB; Fong WC; Wong KS; Yu SC
    Ann Neurol; 2015 Mar; 77(3):478-86. PubMed ID: 25557926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese.
    Uehara T; Tabuchi M; Mori E
    Eur J Neurol; 2005 Mar; 12(3):218-22. PubMed ID: 15693812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study.
    Mok VC; Lam WW; Fan YH; Wong A; Ng PW; Tsoi TH; Yeung V; Wong KS
    J Neurol; 2009 May; 256(5):750-7. PubMed ID: 19252811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral blood flow evaluation of intensive rosuvastatin therapy in stroke/transient ischemic attack patients with intracranial arterial atherosclerotic stenosis study: Rationale and design.
    Zhang X; Zhou Y; Zhang S; Ding W; Lou M
    Brain Behav; 2017 Jun; 7(6):e00689. PubMed ID: 28638702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.